LumiraDx receives approval for its COVID-19 Antigen test for use in India

Today, LumiraDx, a next-generation point of care diagnostics testing company announced it has received emergency use approval by India Central Drugs Standard

Related Keywords

India ,Italy ,Japan ,United States ,United Kingdom ,London ,City Of ,America ,Yogesh Singh ,David Walton ,Exchange Commission ,Billmelinda Gates Foundation ,India Central Drugs Standard Control Organisation ,Drug Administration ,National Health Service ,Central Drugs Standard Control Organisation ,Emergency Use Authorization ,Lumiradx Chief Commercial ,Lumiradx General Manger ,Lumiradx Platform ,South America ,Securities Litigation Reform Act ,Proxy Statement ,Medical News ,Launch ,India And ,Accurate ,Europe ,Portfolio ,Hospital ,Cute ,Efficient ,Performance ,